Order Entry
Canada
ContactUsLinkComponent
SensoLyte® 440 West Nile Virus Protease Assay Kit (Fluorimetric), AnaSpec Inc.
SensoLyte® 440 West Nile Virus Protease Assay Kit (Fluorimetric), AnaSpec Inc.
Catalog # 103010-398
Supplier:  Anaspec
CAS Number:  
SensoLyte® 440 West Nile Virus Protease Assay Kit (Fluorimetric), AnaSpec Inc.
Catalog # 103010-398
Supplier:  Anaspec
Supplier Number:  AS-72079
CAS Number:  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/ca/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

Specifications

  • Size:
    500 Assays (96-well plate) or 1250 Assays (384-well)
  • Cat. no.:
    103010-398
  • Storage Temperature:
    – 20 °C
  • Includes:
    The assays can be performed in a convenient 96-well microplate format, kit includes essential components and detailed protocol and references
  • Supplier No.:
    AS-72079

Specifications

About this item

West Nile virus (WNV) causes severe neurological disease and fatalities in both human and animal hosts

The SensoLyte® 440 West Nile Virus Protease Assay Kit provides a convenient homogenous assay for high throughput screening of WNV protease inhibitors and for continuous assay of NS3 protease activity using a fluorogenic Pyr-RTKR-AMC peptide. Upon NS3 protease cleavage, Pyr-RTKR-AMC generates the AMC fluorophore that has bright blue fluorescence and can be detected at excitation/emission=354 nm/442 nm.

There is currently no effective vaccine or antiviral drug to protect against WNV infection. The West Nile virus NS3 protease, essential for the proteolytic processing of the viral polyprotein precursor, is a promising target for the development of anti-WNV drugs.